跳至主要内容
临床试验/JPRN-UMIN000029541
JPRN-UMIN000029541已完成未知

Comparison of Platelet Aggregation Response in Switching Antiplatelet Therapy or Doses in Elder Patients After Coronary Stenting - CHAPERO

Juntendo University Graduate School of Medicine Department of Cardiovascular Medicine0 个研究点目标入组 400 人开始时间: 2017年10月16日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
400

研究概览

简要总结

Switching from clopidogrel 75 mg to prasugrel 2.5 mg significantly lowered and aggregated the PRU value. Whereas, dose reduction of prasugrel had a significantly lower proportion of bleeding risk over one year after PCI than the continuation of prasugrel 3.75 mg, and was an independent predictor for bleeding risk with reference of continuation of prasugrel 3.75 mg.

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1 Patients who survive within 1 year 2 Patients who are indicated for revascularization such as percutaneous coronary intervention or bypass 3 Patients who are judged inappropriate inthis trial by director

研究者

发起方
Juntendo University Graduate School of Medicine Department of Cardiovascular Medicine

相似试验

Comparison of Platelet Aggregation Response in... | 临床试验